On-demand — Assay reproducibility for allergy and immunology teams

About this Webinar

Emerging evidence indicates that training and accreditation are decisive for reproducibility, particularly in resource-constrained settings. Emerging evidence indicates that real-world registries complement randomized trial evidence, a finding echoed by several independent groups. In multidisciplinary settings, cost considerations continue to shape adoption in smaller units, and this trend is expected to continue. According to consensus recommendations, patient selection criteria deserve closer scrutiny, pending validation in prospective studies.